Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Aïda Amer/Axios

New and expecting mothers are navigating a morass of science and medicine as they try to mitigate the risks of COVID-19 to themselves and their babies.

Why it matters: Pregnancy can be hard during normal times, but there's an extra layer of uncertainty during the pandemic as COVID-19 presents unique risks to pregnant people.

Driving the news: NIAID director Anthony Fauci said Wednesday that roughly 20,000 pregnant people had been vaccinated in the U.S. so far, and no complications have been seen.

  • But "it takes us quite a bit of time to follow the woman and her fetus and then her baby and see how things will turn out," Geeta Swamy, associate professor of OB/GYN and an associate vice president for research at Duke, points out.
  • The Pfizer BioNTech and Moderna vaccines authorized for use in the U.S. don't use live or attenuated viruses and studies of pregnant animals suggest they are safe, experts say. However, pregnant and lactating people were not included in the initial vaccine trials.
  • "No one anticipates that there will be an impact on fetal development or growth," Swamy tells Axios. But some are concerned potential side effects from the vaccine, including fever and inflammation, could stress the fetus.
  • "We have good theoretical data and those risks aren’t high, but ultimately individuals have to make that choice and it is hard," says Naima Joseph, who specializes in maternal fetal medicine at Emory University's School of Medicine.

Between the lines: This leaves pregnant people to weigh the risks. The CDC doesn't take a stance, stating, "People who are pregnant and part of a group recommended to receive the COVID-19 vaccine may choose to be vaccinated."

On the one hand: Data show pregnant people are at higher risk of developing severe COVID-19 compared to women of the same age who are not pregnant, and there appears to be a risk of preterm birth.

  • Pregnant people are "more likely to be hospitalized, to require intensive care, to require ECMO, to be ventilated, and to die, unfortunately," Emory Healthcare's Denise Jamieson told a JAMA webcast Monday.

On the other hand: Clinical trials, including those for COVID-19 vaccines, typically don't include pregnant or lactating people, leaving a gap in knowledge about the effect of one of the most important pandemic-fighting tools.

  • Catherine Spong, chief of the Division of Maternal-Fetal Medicine and vice chair of the OB/GYN department at UT Southwestern, told the webcast many experts are "absolutely" disappointed pregnant or lactating people were not included in the phase III trials.
  • A congressional task force met for years and came up with recommendations and an implementation plan on how to include these two groups, and "yet, still, again, they were not included in something where they were clearly at higher risk," said Spong, who co-authored a piece in JAMA this week about COVID-19 vaccination for pregnant and lactating people.

One open question is whether a baby is protected if their pregnant mother is vaccinated.

  • Pregnant people are recommended to get the flu and Tdap vaccines because the newborn will have some immunity for the first several months, Swamy said.
  • A handful of recent studies, including one by Joseph, found COVID-19 antibodies from infection cross the placenta.
  • But antibodies weren't transferred at as high of a rate as "we know the placenta can do" from studies of other pathogens, Joseph says. "We don't know what that means for vaccines yet," but are now conducting studies.

Other pressing questions...

  • Can a mother's infection affect the fetus? "We think infection can occur but it is quite rare," Joseph says. "Over a year of data and deliveries, there doesn’t seem to be increased risk for birth defects or anything besides preterm delivery," mostly in people with severe disease.
  • Can caretakers like grandparents help out safely? Jamieson and Spong recommend caretakers get vaccinated and wait two weeks after the second shot (for the mRNA vaccines). They should wear masks and practice good hygiene.
  • Breastfeeding women can safely get the vaccine, Swamy says, which is supported by the Academy of Breastfeeding Medicine.

What to watch: Pfizer and J&J, which filed for emergency use authorization of its COVID-19 vaccine, plan to begin clinical trials for pregnant people, and the CDC is monitoring all vaccinated people through its v-safe program.

  • Moving forward, Joseph says, "the highest priorities are maternal inclusion in studies that look at adaptive immunity because that's the only way to design rational vaccines for this population."

Editor’s note: This story has been updated to reflect that Joseph specializes in maternal fetal medicine at Emory University School of Medicine.

Go deeper

Feb 11, 2021 - Health

Biden administration purchases 200 million additional vaccine doses

President Biden in the Oval Office of the White House on Feb. 11. Photo: Doug Mills/The New York Times/Bloomberg via Getty Images

The federal government purchased an additional 200 million doses of the coronavirus vaccine, President Biden announced Thursday during a tour of the National Institutes of Health.

The big picture: Biden said the U.S. is on track to have enough supply of the vaccine to inoculate 300 million Americans by the end of July. That comes out to roughly 600 million doses, boosting "supply in the United States by 50 percent," as first reported by the Washington Post.

Why vaccine production is taking so long

Illustration: Eniola Odetunde/Axios

COVID-19 vaccine makers are under intense pressure to rev up production, but the scale of the challenge is unprecedented — and the speed of production is limited.

Why it matters: Even with help from the federal government and outside companies, vaccine-making is a complex, time-consuming biological process. That limits how quickly companies like Pfizer and Moderna can accelerate their output even during a crisis.

Feb 12, 2021 - Politics & Policy

Biden blasts Trump's COVID vaccination efforts: "Did not do his job"

President Biden. Photo: Oliver Contreras/Sipa/Bloomberg via Getty Images

President Biden on Thursday slammed his predecessor for "not doing his job in getting ready for the massive challenge of vaccinating hundreds of millions of Americans."

Driving the news: Biden's remarks at the National Institutes of Health came not long after his administration signed final contracts with Pfizer and Moderna to purchase an additional 200 million doses of the coronavirus vaccines.